Skip to main content

Published locations for ‘Modest’ benefit for lecanemab in Alzheimer’s disease, but adverse events are common

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ‘Modest’ benefit for lecanemab in Alzheimer’s disease, but adverse events are common

User login

  • Reset your password
  • /content/modest-benefit-lecanemab-alzheimers-disease-adverse-events-are-common
  • /familypracticenews/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease
  • /internalmedicinenews/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease
  • /neurologyreviews/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease
  • /jcomjournal/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease-adverse
  • /psychiatry/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease-adverse
  • /internalmedicine/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease
  • /neurology/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease-adverse
  • /familymedicine/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers-disease
  • /clinicalpsychiatrynews/article/259846/alzheimers-cognition/modest-benefit-lecanemab-alzheimers